What you're seeing is that generalist money is getting very worried and thinking that maybe the healthcare trade is over and they're rotating into something else.

John Fraunces

Categorized in : Business

This is one of the strongest positions of pricing power, because you won't see an HMO push back on prices for a drug that only affects 20,000 patients or so.